Ben G. Marshall

University Hospital Southampton NHS Foundation Trust — United Kingdom

Medicine · Health Sciences

32h-index4.0kcitations115works7.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(29), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(23), Mycobacterium research and diagnosis(16), Long-Term Effects of COVID-19(14), COVID-19 Clinical Research Studies(10)

Publications102 total

P28 Little women looking into antifibrotic tolerance in relation to weight, dose, female gender and ethnicity
2025
P220 A service evaluation of the endobronchial ultrasound service (EBUS), including molecular diagnoses and patient satisfaction at university hospital service (UHS)
2025
S157 A single centre retrospective study investigating the utility of bronchoalveolar lavage in the diagnosis of interstitial lung disease
2025
The effectiveness and experience of Endobronchial Ultrasound
Lung Cancer·2025
Air pollution and alveolar health
European Respiratory Review·2025· 2 citedOpen Access
One-Year Review of Novel “Virtual” Pneumonia Follow-Up Clinic a Decade From Inception
Cureus·2025· 1 citedOpen Access
Options for mitigating converter blocking during clearance of DC faults
IET conference proceedings.·2025· 1 cited
Amyotrophic lateral sclerosis in a patient with chronic lymphocytic leukaemia and drug related sarcoid-like reaction
BMC Neurology·2025· 2 citedOpen Access
Breathlessness and cough in the acute setting
Medicine·2024
P162 Incidental interstitial lung abnormalities identified within a lung cancer screening programme: initial experience within a pilot UK site
2024
Amyotrophic Lateral Sclerosis developing in a patient with Chronic lymphocytic leukaemia and drug related a sarcoid-like reaction; teasing apart multiple diagnoses
2024Open Access
The impact of the COVID-19 pandemic on the latent tuberculosis service in Southampton
2024
Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2
Cell Reports Medicine·2024· 5 citedOpen Access
P86 Adverse events after anticoagulation in COVID-19 positive inpatients: a triple cycle audit against NICE guidance NG191
2023Open Access
Genetic and geographic influence on phenotypic variation in European sarcoidosis patients
Frontiers in Medicine·2023· 10 citedOpen Access
LKB1 depletion-mediated epithelial–mesenchymal transition induces fibroblast activation in lung fibrosis
Genes & Diseases·2023· 6 citedOpen Access
A Qualitative Study of Medical Students’ Perspectives on Distance Learning During COVID-19
Medical Science Educator·2023· 2 citedOpen Access
Spatial Transcriptomic Validation of a Biomimetic Model of Fibrosis Enables Re-Evaluation of a Therapeutic Antibody Targeting LOXL2
SSRN Electronic Journal·2023Open Access
Predicting the risk of chest radiograph abnormality 12-weeks post hospitalisation with SARS CoV-2 PCR confirmed COVID-19
Respiratory Research·2022· 1 citedOpen Access
A rare infective cause for recurrent exacerbations and poor asthma control – <i>Mycobacterium kumamotonense</i>
JRSM Open·2022· 1 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Mark G. Jones(14), Donna E. Davies(11), Aiman Alzetani(10), Paul Elkington(10), Luca Richeldi(9), Sophie Fletcher(8), R J Shaw(8), Franco Conforti(7), Yihua Wang(7), A Wangoo(7), Marc Tebruegge(7), Liudi Yao(5), Sanjay Jogai(5), Salah Mansour(5), Juanjuan Li(4), Christopher J. Brereton(4), Yilu Zhou(4), David C. Hancock(4), Christian H. Ottensmeier(4), Julian Downward(4)